Restart Life Sciences Strengthens Operational Infrastructure to Scale "Better-for-You" Portfolio

Executive Summary of Most Recent Release (May 8, 2026)

• Restart Life Sciences Corp. announced the appointment of a specialized Project Manager to oversee scaling of its functional food and CPG portfolio, including Holy Crap Foods Inc.
• The Company issued 1,600,000 common shares to officers, directors, and consultants tied to specific performance milestones (acquisition of brand assets, growth initiatives, market cap targets).
• This follows the recent appointment of Lindsay Hamelin to the Board of Directors.
• Issuance is a related party transaction under MI 61-101; value does not exceed 25% of Company's market capitalization.
• Shares subject to Canadian Securities Exchange approval and a four-month and one day hold period.

Evaluation of News Significance

• The news is operational scaling rather than a fundamental valuation driver change (e.g., new major contract or acquisition).
• Issuance of 1,600,000 shares introduces dilution; however, it is milestone-based equity compensation rather than immediate cash raise at discount.
• Revenue growth ($106k/month run rate) validates the need for operational infrastructure (Project Manager), making this a logical follow-up to April revenue beats.
• Related party transaction status requires scrutiny but does not inherently negate value if milestones are met.

Corporate Profile

• Company: Restart Life Sciences Corp. (CSE: HEAL implied).
• Business Model: Functional foods, Consumer Packaged Goods (CPG), and wellness products.
• Flagship Project/Brand: Holy Crap Foods Inc. (Acquired Feb 2026).
• Product Focus: Gut health, functional nutrition, clean-label snacks (Superseed, Oatmeal Variety Packs).